Inventor
SCHOLS DOMINIQUE
BE33 patents
⚠️ This page may combine multiple inventors who share the name “SCHOLS DOMINIQUE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ANORMED INC
13 patentsUS6872714B1Mar 29, 2005
Methods to modulate conditions mediated by the CXCR4 receptor
ANORMED INC35 citations96
US6750348B1Jun 15, 2004
Chemokine receptor binding heterocyclic compounds
ANORMED INC61 citations96
US6864265B2Mar 8, 2005
Chemokine receptor binding heterocyclic compounds
ANORMED INC42 citations95
US6835731B2Dec 28, 2004
Chemokine receptor binding heterocyclic compounds
ANORMED INC53 citations95
US6506770B1Jan 14, 2003
Antiviral compounds
ANORMED INC53 citations94
US7354934B2Apr 8, 2008
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
ANORMED INC34 citations92
US7354932B2Apr 8, 2008
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
ANORMED INC27 citations92
US7160872B2Jan 9, 2007
Methods to treat conditions mediated by chemokine receptors
ANORMED INC20 citations92
US7091217B2Aug 15, 2006
Chemokine receptor binding heterocyclic compounds
ANORMED INC31 citations92
US6734191B2May 11, 2004
Chemokine receptor binding heterocyclic compounds
ANORMED INC35 citations92
US6756391B2Jun 29, 2004
Antiviral compounds
ANORMED INC23 citations91
US7183273B2Feb 27, 2007
Chemokine receptor binding heterocyclic compounds
ANORMED INC2 citations62
US7022717B2Apr 4, 2006
Chemokine receptor binding heterocyclic compounds
ANORMED INC2 citations61
GENZYME CORP
9 patentsUS7291631B2Nov 6, 2007
CXCR4 chemokine receptor binding compounds
GENZYME CORP50 citations95
US7863293B2Jan 4, 2011
CXCR4 chemokine receptor binding compounds
GENZYME CORP24 citations92
US7709486B2May 4, 2010
CXCR4 antagonists
GENZYME CORP20 citations91
US7414065B2Aug 19, 2008
Methods to modulate conditions mediated by the CXCR4 receptor
GENZYME CORP20 citations91
US7550484B2Jun 23, 2009
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
GENZYME CORP19 citations83
US10322111B2Jun 18, 2019
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
GENZYME CORP1 citations71
US7396840B2Jul 8, 2008
Chemokine receptor binding heterocyclic compounds
GENZYME CORP1 citations62
US7629337B2Dec 8, 2009
Chemokine receptor binding heterocyclic compounds
GENZYME CORP1 citations52
US7807694B2Oct 5, 2010
Chemokine receptor binding heterocyclic compounds
GENZYME CORP0 citations51
ANORMED
3 patentsABLYNX NV
3 patentsUS9803018B2Oct 31, 2017
Amino acid sequences directed against cellular receptors for viruses and bacteria
ABLYNX NV2 citations71
US10273305B2Apr 30, 2019
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
ABLYNX NV2 citations69
US11046773B2Jun 29, 2021
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
ABLYNX NV0 citations59